AUG 02, 2016 5:32 AM PDT

‘Kissing Disease' Virus Now Linked to Breast Cancer

WRITTEN BY: Xuan Pham

One of the most common viruses in the world – and one of the few that’s actually shown to cause cancer – has now been linked to a new cancer type: breast cancer. Indeed, more than 90 percent of the world’s population is infected with the Epstein-Barr virus (EBV), and mounting evidence suggests this viral infection is anything but benign.
 
Epstein-Barr virus | Image: Albert Eistein College of MedicineSince its discovery in the 1960s, the Epstein-Barr virus has proven to be increasingly more complex. Also called human herpesvirus 4 (HHV-4), EBV is one of eight viruses in the herpes family. It’s infamous for causing “the kissing disease,” otherwise known as mono (short for mononucleosis), in teenagers.
 
But even more threatening than causing swollen lymph glands and fevers, EBV was the first virus shown to cause cancer directly. In particular, EBV infection is linked to two types of lymphomas (Burkitt’s and Hodgkin’s), stomach cancer, and some types of head and neck cancer (nasopharyngeal carcinoma). Some scientists have suspected EBV may also cause cancer of the breast, but the evidence hasn’t been causal – until now.
 
Working with breast cells called primary mammary epithelial cells (MECs), researchers at the Beth Israel Deaconess Medical Center (BIDMC) sought out to study whether EBV could influence the fate of these cells. Indeed, when the MECs were exposed to EBV, the cells transformed into a stem-cell-like state, which allowed them to proliferate without control. This is the first sign that the cells have turned down a cancerous path.
 
Then, when those cells were transplanted into mice, breast tumors formed. This is the second – and quite convincing evidence, showing that EBV turned normal cells into cancer-prone cells.
 
When the team examined the profile of the infected cells, they found changes similar to those of high-grade, estrogen-receptor-negative breast tumors. This line of evidence reinforce the strength of the virus to wreak havoc in the body.
 


"We think that if a young woman develops EBV during her teenage years or later, her breast epithelial cells will be exposed to the virus and can be infected. While for most individuals, there will be no long-term consequences, in some the infection may leave genetic scars and change the metabolism of these cells," said Gerburg Wulf, physician scientist at the BIDMC, and senior study investigator. "While these are subtle changes, they may, decades later, facilitate breast cancer formation."
 
But there’s a silver lining from this discovery, and it may come in the form of a vaccine. "The findings further make the case for an EBV vaccine that might protect children from infection and later EBV-associated malignancies," said Wulf. Scientists are currently testing a few EBV protein targets for vaccine discovery, however, the virus is complex and no vaccines are available as of yet.

Additional source: BIDMC press release
 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 26, 2021
Genetics & Genomics
Connecting Bacterial Genes to Human Disease
MAY 26, 2021
Connecting Bacterial Genes to Human Disease
This kind of research gets us closer to using fecal samples to get a snapshot of the microbiome, and make disease risk p ...
JUN 06, 2021
Cancer
New drug reduces tumor size in lung cancer patients with KRAS gene mutation
JUN 06, 2021
New drug reduces tumor size in lung cancer patients with KRAS gene mutation
The most recent results from the CODEBREAK 100 phase 2 clinical trial support the use of the drug sotorasib to reduce tu ...
JUN 24, 2021
Clinical & Molecular DX
Test Lets Cancer Patients Track Whether Their Treatment Is Working in Real Time
JUN 24, 2021
Test Lets Cancer Patients Track Whether Their Treatment Is Working in Real Time
Researchers from Singapore have created the ExoSCOPE, the world’s first blood test for tracking whether or not a p ...
JUL 08, 2021
Genetics & Genomics
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
JUL 08, 2021
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
Children with Down syndrome have a significantly higher likelihood myeloid leukemia occurring in the first five years of ...
AUG 24, 2021
Technology
CRISPR Helps Identify New Therapeutic Target for Leukemia
AUG 24, 2021
CRISPR Helps Identify New Therapeutic Target for Leukemia
Researchers may have found a new druggable target in patients with acute myeloid leukemia (AML), thanks to a CRISPR scre ...
SEP 16, 2021
Technology
Scientists Create Tiny Replicas Of The Pancreas To Study New Drugs
SEP 16, 2021
Scientists Create Tiny Replicas Of The Pancreas To Study New Drugs
Pancreatic cancer it’s often hard to diagnose in its early stages, resulting in patients having more advanced canc ...
Loading Comments...